Mental Health Symptoms among General Practitioners Facing the Acute Phase of the COVID-19 Pandemic: Detecting Different Reaction Groups.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
28 03 2022
Historique:
received: 24 12 2021
revised: 13 03 2022
accepted: 24 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

During the 2020 first wave of the COVID-19 pandemic, general practitioners (GPs) represented the first line of primary care and were highly exposed to the pandemic risks, with a consequent risk of developing a wide range of mental health symptoms. However, scant data are still available on factors associated with a worse outcome. The aim of the present study was to investigate mental health symptoms in 139 GPs in the aftermath of the first COVID-19 national lockdown in Italy, detecting groups of subjects with different depressive, anxiety, and post-traumatic stress symptom severity. The impact of the mental health symptoms on quality of life and individual functioning were also evaluated. A cluster analysis identified three groups with mild (44.6%), moderate (35.3%), and severe psychopathological burden (20.1%). Higher symptom severity was related to younger age, fewer years in service as GPs, working in a high incidence area for the pandemic, having a relative at risk of medical complications due to COVID-19, besides more severe global functioning impairment, burnout, and secondary traumatic stress. The present findings showed that GPs, forced to perform their professional activity in extremely stressful conditions during the COVID-19 pandemic, were at high risk of developing mental health problems and a worse quality of life.

Identifiants

pubmed: 35409690
pii: ijerph19074007
doi: 10.3390/ijerph19074007
pmc: PMC8998411
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Psychiatr Serv. 2008 Jan;59(1):91-5
pubmed: 18182545
J Psychiatr Res. 2007 Jan-Feb;41(1-2):119-30
pubmed: 16460760
J Consult Clin Psychol. 2000 Oct;68(5):748-66
pubmed: 11068961
J Affect Disord. 2010 Jun;123(1-3):249-57
pubmed: 19765828
Depress Anxiety. 2001;14(2):67-78
pubmed: 11668659
Acta Biomed. 2020 May 11;91(2):83-88
pubmed: 32420931
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
Healthcare (Basel). 2020 Jun 03;8(2):
pubmed: 32503304
Front Psychol. 2020 Oct 02;11:567201
pubmed: 33132972
JAMA Netw Open. 2020 May 1;3(5):e2010185
pubmed: 32463467
Br J Psychiatry. 2004 Aug;185:127-33
pubmed: 15286063
Eur J Public Health. 2020 Sep 1;30(Suppl_4):iv36-iv38
pubmed: 32894291
J Psychiatr Res. 2019 Feb;109:52-58
pubmed: 30502492
J Anxiety Disord. 2014 Aug;28(6):547-52
pubmed: 24983795
JAMA. 2006 Aug 2;296(5):560-6
pubmed: 16882962
Eur J Gen Pract. 2020 Dec;26(1):58-60
pubmed: 32349550
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Psychiatry Res. 2015 Jan 30;225(1-2):64-69
pubmed: 25454114
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
J Clin Psychiatry. 2004 Aug;65(8):1120-7
pubmed: 15323599
Transl Psychiatry. 2020 Oct 13;10(1):348
pubmed: 33051440
J Trauma Stress. 2005 Oct;18(5):485-9
pubmed: 16281246
Behav Res Ther. 2003 Dec;41(12):1489-96
pubmed: 14705607
Compr Psychiatry. 2014 Feb;55(2):357-62
pubmed: 24269194
BJGP Open. 2021 Aug 24;5(4):
pubmed: 34172477
Depress Anxiety. 2019 Jun;36(6):490-498
pubmed: 30681235
Brain Behav Immun. 2020 Jul;87:11-17
pubmed: 32240764
Ir J Med Sci. 2022 Feb;191(1):93-96
pubmed: 33660115
Int J Environ Res Public Health. 2020 Aug 26;17(17):
pubmed: 32858810
Riv Psichiatr. 2021 Jul-Aug;56(4):189-197
pubmed: 34310576
Clin Pract Epidemiol Ment Health. 2006 Jul 26;2:17
pubmed: 16869979
Minerva Anestesiol. 2021 May;87(5):556-566
pubmed: 33432793
Risk Manag Healthc Policy. 2021 Sep 24;14:3987-3992
pubmed: 34602826
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
Aust J Gen Pract. 2021 Oct 29;50:
pubmed: 34727568
Eur J Psychotraumatol. 2021 Dec 9;12(1):1-14
pubmed: 34912501
J Affect Disord. 2022 Feb 1;298(Pt A):209-216
pubmed: 34728285
BMJ. 2020 Mar 30;368:m1279
pubmed: 32229477
JAMA. 2020 Jun 2;323(21):2133-2134
pubmed: 32259193
J Investig Med. 2020 Oct;68(7):1228-1234
pubmed: 32747387
Soc Psychiatry Psychiatr Epidemiol. 2012 Jun;47(6):1001-11
pubmed: 21681455
Ned Tijdschr Geneeskd. 2020 Mar 19;163:
pubmed: 32191407
Int J Environ Res Public Health. 2021 Sep 17;18(18):
pubmed: 34574723
J Public Health (Oxf). 2021 Dec 8;43(Suppl 3):iii34-iii42
pubmed: 34642765
J Affect Disord. 2016 Mar 15;193:267-73
pubmed: 26774513
Psychiatry Res. 2021 Apr;298:113763
pubmed: 33545425
J Affect Disord. 2021 Feb 15;281:244-246
pubmed: 33338842
BMC Public Health. 2012 May 15;12:249
pubmed: 22455604
Epidemiol Serv Saude. 2020;29(2):e2020166
pubmed: 32348404
Ulster Med J. 2021 Sep;90(3):151-156
pubmed: 34815593
J Affect Disord. 2020 Nov 1;276:205-211
pubmed: 32697700
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Front Public Health. 2021 Feb 03;9:623904
pubmed: 33614587
Aust J Gen Pract. 2020 Dec;49(12):791-795
pubmed: 33254202
J Affect Disord. 2020 Oct 1;275:48-57
pubmed: 32658823
Emerg Med J. 2014 Mar;31(3):242-7
pubmed: 23314206
Can J Psychiatry. 2009 May;54(5):302-11
pubmed: 19497162
Brain Behav Immun. 2020 Aug;88:559-565
pubmed: 32330593
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941

Auteurs

Claudia Carmassi (C)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Valerio Dell'Oste (V)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.

Filippo Maria Barberi (FM)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Carlo Antonio Bertelloni (CA)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Virginia Pedrinelli (V)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.

Liliana Dell'Osso (L)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH